Co-Targeting Biomimetic Nanoparticles Alleviate Atherosclerosis by Inhibiting the Vicious Circle Between Inflammation and Lipids

Chengxi Wu, Yaoyao Li, Yuting Liu, Xueqin Wang, Ping Yuan, Maochang Xu, Yiping Deng, Zongquan Zhang, Chunhong Li, Xiangyu Zhou · 2025

Read Co-Targeting Biomimetic Nanoparticles Alleviate Atherosclerosis by Inhibiting the Vicious Circle Between Inflammation and Lipids by Chengxi Wu, Yaoyao Li, Yuting Liu, Xueqin Wang, Ping Yuan, Maochang Xu, Yiping Deng, Zongquan Zhang, Chunhong Li, Xiangyu Zhou (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12750338.txt.

Description

Chengxi Wu and nine co-authors built a two-target nanoparticle to treat atherosclerosis, the artery disease driven by fat build-up and inflammation, in a study published in two thousand twenty-five. The two feed each other: oxidized fat harms the vessel wall, and inflamed cells then hold more fat. The team loaded the drug simvastatin into tiny fat-based carriers and coated them with platelet membrane so they would home to both vessel wall cells and immune cells.

In cell tests, the coated particles cut foam cell build-up and calmed inflammation signals. In mice prone to the disease, they reached plaques, proved safe, and slowed disease. The authors say hitting fat and inflammation at once can break the loop that keeps plaques growing.

Catalog record

CREATORChengxi Wu, Yaoyao Li, Yuting Liu, Xueqin Wang, Ping Yuan, Maochang Xu, Yiping Deng, Zongquan Zhang, Chunhong Li, Xiangyu Zhou
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12750338

Browse the full library · About the Tower of Babel